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 The emergence of antibiotic resistances has raised concerns in society about the wide-
spread use of antibiotics, such as monensin, as growth enhancers in agriculture. Pressure to find 
alternatives has increased since the European Union banned the use of ionophorous antibiotics. 
Butyrate supplementation has been found to enhance growth in pre-weaned calves and it has 
been recently suggested to enhance growth in post-weaned heifers. In a recent study by Rice in 
2017, there was a quadratic (P=0.03) response for coccidia counts as sodium butyrate was 
increased, with the lowest counts being at the intermediate doses.  This suggested that butyrate 
has the potential to decrease coccidian in post-weaned heifers. Monensin is also used as a 
coccidiostat. While the objective of the study as a whole was to determine if sodium butyrate can 
replace monensin in the prevention of coccidiosis and in enhancing growth and feed efficiency, 
this report focuses only on the prevention of coccidiosis. At this time, only six of the forty 
Holstein heifers entered the study.  The design was a 2 X 2 factorial arrangement of treatments in 
a randomized complete block design. Heifers were randomly assigned to 1 of 4 treatments: (1) 
carrier (control; C); (2) 0.75 g SB/kg of body weight + carrier (SB); (3) 1.0 mg M/kg of body 
weight + carrier (M); (4) (0.75 g SB/kg of body weight and 1.0 mg M/kg of body weight + 
carrier (SB/M). Heifers entered the study and were trained to Calan doors from week 12 to 13 
age of life.  Treatment began on week 14 of life and continued for 12 weeks.  Fecal samples were 
taken from each calf weekly beginning in the covariate period for determination of coccidia. 
(Measurements were also taken to evaluate the growth of post weaned calves and apparent total 
tract nutrient digestibility). Oocyte counts were determined through the modified Wisconsin 
sugar floatation method.   Due to the small sample size a statistical analysis was unable to be 





as treatment progressed. This indicates that both sodium butyrate and monensin have the ability 
to decrease the shedding of coccidian oocytes, though the statistical significance is not known at 
this time. 
INTRODUCTION 
IMPORTANCE OF DAIRY INDUSTRY 
 The dairy industry is extremely important to the economy of the globe. In 2011, there 
was estimated to be about 260 million dairy cows globally (IDF, 2013).  In 2010, global milk 
production represented 8.9% of the value of all agricultural products (IDF, 2013). In some 
countries, milk production accounts for over 20% of their total agricultural value (IDF, 2013). 
The dairy industry employs up to 8% of the labor force in some countries (IDF, 2013). The dairy 
industry is expected to steadily grow due to the high demand for quality animal protein as the 
global population increases and economies emerge in developing countries (IDF, 2013). The 
dairy industry is especially important to developing countries, and it is responsible for the 
employment of approximately 750 million people on a small-scale dairy farms (IDF, 2013). In 
the United States in 2012, milk production totaled at $35.5 billion, or 9% of United States 
agricultural sales (USDA NASS, 2012). The USDA predicts that the export of dairy products 
will increase from $4.6 billion in 2016 to $9.5 billion in 2026 (USDA, 2017). Quality dairy 
products are in constant demand and this is unlikely to change. The dairy industry is a crucial 
part of the global economy and the economy of the United States. It is imperative for research to 







DEVELOPMENT OF CALVES 
 Calves are born with underdevelopment digestive system which develops as the calf ages. 
The food that the calf ingests in the beginning of its life has a huge impact on the development of 
the calf’s digestive system. When a calf is born, it cannot digest feed in the same way that mature 
cows digest feed. The rumen, reticulum, and omasum are not developed or functional.  There is 
an esophageal groove that allows the ingested liquid material to pass directly into the abomasum 
(Hegland et. al., 1957). The abomasum, the gastric stomach compartment, is where early 
digestion occurs in young calves, making young calves function like monogastric animals 
(Heinrichs, 2005). Because of this, the diet of a calf in the first 8 weeks of its life is mainly 
liquid, colostrum and milk or a milk replacer. Milk replacers are used instead of milk because 
they are less costly than milk and do not significantly affect the growth rate of the calves (Jaster 
et. al., 1989). However, a purely liquid diet does not promote optimal ruminal development. 
In order to transition from a monogastric animal to a ruminant, the rumen must be stimulated 
to develop. Certain feed requirements must be met to optimize ruminal development (Heinrichs, 
2005). The epithelial layer of the rumen is responsible for the absorption if the nutrients digested 
in the rumen. Papillae exist in the rumen to increase the surface area of the epithelial layer to 
increase absorption. It has been found that early introduction of solid feed can stimulate the 
rumen to develop more quickly (Heinrichs, 2005). The ingestion of dry feed and the introduction 
of the microbial community result in the production of volatile fatty acids, which have been 
found to stimulate the development of the rumen. Concentrates and diets with casein, starch, 
cellulose, and minerals induce the development of the rumen better than a purely forage diet 
(Heinrichs, 2005). Butyrate and propionate are two volatile fatty acids that have been shown to 





microbes in the rumen as a by-product of carbohydrate digestion. The types of microbes in the 
rumen determine the amount of volatile fatty acids produced. Gram-negative bacteria increase 
the amount of propionate while gram-positive bacteria increase the amounts of acetate and 
butyrate.   
Calves that have a more developed rumen at a younger age are more beneficial to farmers. 
They grow more quickly and more efficiently and can mature at a younger age. This is important 
to farmers because heifers consume resources without producing milk, meaning that farmers 
must spend money on heifers without making money from them in milk sales. Consequently, the 
sooner a heifer matures, the sooner she can be bred and become a source of income to the farmer, 
and this decreases the cost of feeding heifers (Heinrichs et. al., 2013). Optimizing the 
development, growth, and feed efficiency of calves and heifers can help farmers become more 
lucrative. 
COCCIODIOSIS 
Coccidiosis is an economically significant disease caused by parasitic protozoans from 
the genus Eimeria that infect the intestinal tract of many species, including sheep, chickens, 
turkeys, and cattle. There are many species of Eimeria, and each species of Eimeria infects a 
specific host species. The species that cause coccidiosis in cattle are primarily Eimeria bovis and 
E. zurnii (Quigley et al., 1997). The parasites reproduce in the intestines and cause damage to the 
intestinal tissue. The eggs produced are called oocytes. They are released in the feces and can 
infect other cattle that ingest them.  
Oocytes are essentially ubiquitous in the environment, so it is hard to prevent cattle 





coccidiosis because of their weak immune system, but adults in poor condition with weakened 
immune systems can also develop clinical symptoms. Clinical symptoms include diarrhea, 
bloody diarrhea, dehydration, weakness, and lack of appetite. Most cattle are infected 
subclinically when they are calves and develop a strong immunity towards the parasite by 
adulthood. Subclinical coccidiosis is also detrimental to the calf and the farmer. The parasites 
destroy the lining of the intestine, causing inefficiency of nutrient absorption and decreased 
appetite. This is detrimental to the growth and development of the calves and can lead to future 
inefficiency in the mature animal. The economic loss due to coccidiosis in the United States has 
been estimated to be $100 million (Taylor, 2016). In order to optimize the growth and feed 
efficiency of calves and heifers, coccidiosis must be prevented. 
MONENSIN: COCCIDIOSTAT AND GROWTH ENHANCER 
Monensin is an ionophorous antibiotic which damages bacteria, and to a lesser extent 
coccidian, by damaging the cell membrane so that the cell membrane can no longer effectively 
maintain its proper ion concentrations (Hilton et. al., 1990). Ionophores have been found to have 
coccidiostatic effects on dairy cattle, specifically in younger animals. In one experiment, calves 
fed the ionophore lasalocid shed less oocyts than the control group (Quiglet, et. al., 1997). 
Monensin has been shown to have coccidiostatic affects in cattle as well (Stickdale, 1981). 
Monensin prevented clinical signs of coccidious in 10-week-old Holstein-Friesian calves 
inoculated with oocytes (Fitzgerald and Mansfield, 1973).  However, this antibiotic must be fed 
daily due to the resilience of the protozoans. The only time monensin was found to affect the 
parasites was after they reached the stage of sexual reproduction, because it is after this point that 





1983). Supplementing ionophores such as monensin at an early age has been shown to reduce 
coccidian oocyst shedding. 
Ionophores have the ability to change the microbial population in the rumen. As 
previously stated, ionophores disrupt the ion gradient in the cell membrane of bacteria and 
prevent the bacteria from maintaining adequate rates of cellular growth to sustain survival 
(Russell and Strobel, 1989).  However, ionophores do not affect all bacteria equally. Gram-
positive bacteria have a cell membrane that makes them more susceptible to damage from 
ionophores (Callaway et al., 2003). With ionophorous treatment, the population of Gram-positive 
bacteria is decreased, which provides more nutrients for Gram-negative bacteria to proliferate. 
As previously mentioned, decreasing the population of Gram-positive bacteria will lower 
concentrations of acetate and butyrate, and increasing the population of Gram-negative bacteria 
will increase the concentration of propionate. These conditions increase feed efficiency in 
heifers. Because of this, ionophores such as monensin have also been found to be growth 
enhancers. Much research has been done to support monensin’s ability to increase growth and 
feed efficiency. In one study, cattle fed monensin as a supplement to their diet gained weight 
1.6% faster, ate 6.47% less, and required 7.5% less feed than the cows fed a normal diet 
(Goodrich et. al., 1984). In another study, Heifers fed monensin at 200 and 600 mg/d levels 
gained 0.09 kg/d more than animals on the control diet and had lower dry matter intakes, leading 
to 12.6 and 13.4% greater efficiency in converting feed to body weight gain than control heifers 
(Baile et al., 1982). The supplementation of ionophores in dairy cattle diets increases feed 
efficiency. Monensin decreases feed intake while allowing cattle to maintain similar body weight 






RISE OF ANTIBIOTIC RESISTANCES 
Because of their effect as a growth enhancer, antibiotics including monensin are fed to 
livestock on a large scale. It has been estimated that about 3.7million pounds of antibiotics are 
used in cattle farms as grow enhancers annually in the United States (Mellon et. al., 2001).  The 
extensive use of antibiotics can lead to populations of resistance pathogens, and coccidian is no 
exception. One study on broiler chickens showed that of the 10 Eimeria field isolates, 9 were 
resistant to antibiotcs, and 6 of those were resistant to monensin specifically (Stephan et. al., 
1997). Another study showed that Eimeria meleagrimitis, parasite of turkeys, has the ability to 
develop resistance to monensin as well (Jeffers and Bentley, 1980). However, bacterial 
resistance to ionophores is not well understood. Even so, humans are not treated with 
ionophores, so it is unlikely that ionophore-resisitant bacteria would affect people (Russell and 
Houlihan, 2003). Nevertheless, the European Union has banned antibiotics including ionophores, 
so there is a need to find growth enhancers that are not antibiotics.  
BUTYRATE 
 Butyrate is a volatile fatty acid that is produced by microbial fermentation. Butyrate has 
been found to have many functions in gut cells. Butyrate functions as a source of energy and as a 
cellular mediator (Beford and Gong, 2017). Butyrate has been found to be able to alter gene 
expression, induce cell differentiation, stimulate gut tissue development, induce immune 
modulation, and control diarrhea in multiple species (Bedford and Gong, 2017). Butyrate can act 
as a histone deactylase inhibitor.  Butyrate blocks the actions of histone deactylase molecules, 
resulting in the activation of silent genes (Marks et. al., 2000). Butyrate has been found to have 
anti-inflammatory properties. In humans, one of the most studied mechanisms is the inhibition of 





cytokines, inflammation-inducing enzymes, growth factors, heat shock proteins, and immune 
receptors (Vinolo et al., 2011). In vitro, sodium butyrate induced expression of host defense 
peptides in chicken cell types including macrophages, monocytes, bone marrow cells, jejunal 
cells, and cecal cells (Sunkara et.al., 2011). Butyrate has been found to have antimicrobial 
properties in chickens, in pigs, and in humans. Butyrate has been shown to reduce and prevent 
the colonization of Salmonella in broiler chickens (Fernandez-Rubio et. al., 2009). The reported 
beneficial effects of butyrate supplementation (antimicrobial and anti-inflammatory activities, 
enhancement of growth performance and gut tissue development, modulation of immune 
response and intestinal microbiota) in humans, poultry, and pigs suggest that butyrate could be a 
potential substitute for in-feed antibiotics (Bedford and Gong, 2017). 
Butyrate is also an importance source of energy in cows as well as cellular modulator.  
Supplementing dietary butyrate to newborn calves has been shown to cause the acceleration of 
gastrointestinal tract (GIT) development, including the rumen, abomasum, small intestine, and 
pancreas (Gorka et. al., 2011a). Butyrate can also modulate GIT secretion of peptides and 
hormones (Guilloteau et. al., 2009b). In calves, administration of butyrate directly into the rumen 
stimulated proliferation of epithelial cells and reduced epithelial cell apoptosis, resulting in 
longer papillae (Mentschel et. al., 2001). When butyrate is supplemented in dry feed, it affects 
the rumen. When butyrate is supplemented in liquid feed, it affects the abomasum and small 
intestine. Consequently, butyrate should be added to both dry and liquid feed in calves to 
stimulate development of the entire GIT (Gorka et. al., 2011a).  Butyrate has been shown to 
improve growth, but the exact mechanism has not been determined in detail in ruminants (Gorka 
et. al., 2018). When butyrate was supplemented to calves in milk replacer, the calves has reduced 





Most of the research on butyrate has focused on its effect on pre-weaned calves. In work 
completed at the University of New Hampshire by Rice in 2017, different concentrations of 
sodium butyrate were supplemented in the heifer’s diet (0g/kg of body weight, 0.25g/kg body 
weight, 0.5g/kg of body weight, and 0.75g/kg of body weight). This was believed to be the first 
experiment to evaluate the supplementation of sodium butyrate to post-weaned heifers.  Results 
of this research indicated that as sodium butyrate increased in the diet, dry matter intake was 
unchanged. However, overall weight gain and average daily gain increased with an increase in 
sodium butyrate. While not statistically significant, the observations suggested that as sodium 
butyrate increased in the diet, there was improvement in feed efficiency with no negative effects 
seen in the heifers. There was also a significant quadratic response in coccidian counts as the 
amount of sodium butyrate increased. The results indicated that at a dosage of 0.25g SB/kg of 
body weight was most effective in reducing the shedding of coccidian oocytes.  
Because of the effects of sodium butyrate (SB) on weight gain, average daily gain, feed 
efficiency, final weight and coccidian counts, it appears that sodium butyrate is acting in the gut 
producing responses similar to those when monensin (M) is fed to cattle. With the effort to 
decrease the use of antibiotics across the globe, sodium butyrate is a potential replacement for 
ionophores. The aim of this study is to see if SB is an effective replacement for monensin for 
aiding in prevention of coccidiosis and nutrient absorption through altering the rumen 
environment. While the focus of the study as a whole (completed by Tess Stahl) is to evaluate 
the growth of post-weaned calves and apparent total tract nutrient digestibility of diets containing 
no treatment, 0.75 g SB/kg of body weight, 1 mg of M/kg of body weight, or the combination 
(0.75g SB/kg of bodyweight and 1mg M/kg of body weight), this report is focused specifically 





SB, 1 mg/kg monensin or the combination. It is hypothesized that sodium butyrate will be able to 
replace monensin and the two treatments will yield similar coccidian oocyte counts.  
METHODS 
Forty Holstein heifers will be included in this study. At this point in the study, only six of 
the forty calves entered the study. The design was a 2 X 2 factorial arrangement of treatments in 
a randomized complete block design. Heifers were randomly assigned to 1 of 4 treatments: (1) 
carrier (control; C); (2) 0.75 g SB/kg of body weight + carrier (SB); (3) 1.0 mg M/kg of body 
weight + carrier (M); (4) (0.75 g SB/kg of body weight and 1.0 mg M/kg of body weight + 
carrier (SB/M). The carrier used was soybean meal. Treatments were adjusted weekly according 
to body weight. Heifers entered the study and were trained to Calan doors from week 12 to 13 
age of life. Each heifer was assigned a specific door and assisted with opening the door during 
this week until they were able to enter and exit on their own. Treatment began during week 14 of 
life and the heifers remained on the study for 12 weeks.  
Pre-trial measurements (body weight, heart girth, paunch girth, body length, DMI, blood 
concentrations of β-hydroxybutyrate (BHB), glucose, fecal oocyte count) served as covariates. 
Daily dry matter intake was measured and calves were fed a haylage based diet at the same time 
daily. Total mixed ration samples were taken weekly and composited monthly for nutrient 
analyses.  Orts samples were taken daily and composited by month for each calf.  Feed 
ingredient samples were taken monthly for nutrient analyses. Blood samples for BHB and 
glucose analyses, body weight and skeletal measurements (heart girth, paunch girth, body 
length), and fecal samples for oocyte determination were taken once every Tuesday at 8:00am. 
Body length, heart girth, and paunch girth were measured with weight tape. Body weight was 





gauge needle before the administration of treatments. Samples were collected in 2 10-mL 
vacutainer tubes, 1 containing anticoagulant EDTA and 1 without anticoagulant. Concentrations 
of BHB were obtained utilizing a hand-held electronic blood glucose and ketone monitoring 
system. Apparent total tract digestibility was determined twice during the experiment, once 
during the third week and once during the ninth week.  Chromium oxide (4 g/d) was dosed twice 
daily (12 h intervals) for 7 d, and fecal samples taken over the last three days of the period to 
mimic a 24 h period.  
The coccidian oocyte counts were determined using the Modified Wisconsin sugar float 
test. Sheather’s solution was made by dissolving 90.8 grams of sugar into 71.0 milliliters of hot 
water. The solution was covered and cooled to 38°F before use. To complete the sugar float test, 
3 grams of fecal matter was mixed thoroughly in 10mL of Sheather’s solution. The mixture was 
strained into a 15mL test tube and centrifuged at 1200rpm for 5minutes at 4°C. After 
centrifugation, the test tubes were slightly over-filled with Sheather’s solution, until a meniscus 
formed at the top of the tube. A coverslip was then placed on the meniscus. After 10 minutes, the 
coverslip was placed a slide and viewed under light microscopy. Oocytes were counted at 10x 
over the entire area of the coverslip.  
At this stage of the study, significant statistical analysis was not possible. The sample size 
was too small due to time restrictions to accurately run a statistical analysis. However, the 
preliminary data was analyzed. The oocytes counts were converted to oocytes per kilogram of 
feces. The oocytes per individual heifer were plotted in scatterplots to observe trends. The data 
from each heifer was plotted in two charts. The first was a simple scatterplot with connected 





with a linear regression to determine if there was a relationship between the number of oocytes 
and the progression of treatment throughout the weeks of the experiment.  
RESULTS 
 The individual observations of oocyte counts in eggs per kilogram of feces is summarized 
in Table 1. The observations vary among individual heifers, as seen by the standard deviations in 
Table 2. The total and average oocytes counts for each treatment is summarized in Table 2. In 
the preliminary data, the combination of treatments SB/M yielded the highest average oocyte 
count at 5309.091 eggs/kg. Monensin yielded the second highest oocyte count at 2925.556 
eggs/kg. Sodium butyrate yielded 1512.308 eggs/kg. The lowest oocyte count occurred in the 
control treatment, with 1332.857 eggs/kg. 
Table 1: Individual oocyte counts for each heifer 
Week 
962  




SB/M 967 SB 
0 0 0 2000 3000 14330 15330 
1 0 0 2000 5530 0 2330 
2 0 7000 1670 31330 2330 1000 
3 0 19330 2000 500 0  
4 1000 0 1000 1250 330  
5 0 0 330 0   
6 0 0 330    
7 0 0     
8 0 0     









Table 2: Total observations, oocytes counts, average oocyte counts and standard deviations per 
treatment 
 SB M SB/M Control 
Total observations 13 9 11 7 
Total oocyte count (eggs/kg) 19660 26330 58400 9330 
Average oocyte count (eggs/kg) 1512.308 2925.556 5309.091 1332.857 
Standard deviation (eggs/kg) 4210.165 6572.852 9600.136 771.4859 
 
 The trend in oocyte count over weeks of treatment of sodium butyrate for 962 is 
summarized in Figures 1 and 2. The oocyte count in this heifer remained low and stable. A 
negative relationship was observed. The equation for the linear regression is y = -6.0606x + 
127.27 with an R-squared of 0.0536 (Figure 2). The trend for oocyte count during the course of 
treatment of monensin for 963 in summarized in Figures 3 and 4. The oocyte count in this heifer 
had a peak during week 3 of treatment, but dropped by week 4 and remained stable for the rest 
for the treatment (Figure 3). The negative relationship was observed. The equation for the linear 
regression is y = -555.5x + 5147.6 with an R- squared of 0.0536 (Figure 4). The trend for oocyte 
count during the control treatment for 964 is summarized in Figures 5 and 6. The oocyte count in 
this heifer remained stable, remaining between 1000 and 2000 eggs/kg, until dropping slightly in 
the last two weeks (Figure 5). The negative relationship was observed. The equation for the 
linear regression is y = -322.14x + 2299.3 with an R-squared of 0.8137 (Figure 6). The first 
heifer on combination treatment (965) saw a peak in oocyte count at week 2 (Figure 7). After 
week 2, the oocyte count dropped down. There was a negative trend with a linear regression 
equation of y = -1676.3x + 11126 with an R- squared of 0.067 (Figure 8). 966, the second heifer 
treated with combination began the study with a high oocyte count and it dropped over the 





2800x + 8998 and an R-squared of 0.5119 (Figure 10). 967, the second heifer treated with 
sodium butyrate, had the highest counts in the covariate week and the counts dropped in the 
following weeks (Figure 11).  The linear regression was negative with an equation of y = -7165x 






































962 - Sodium Butyrate





















































































Figure 1: Line chart showing the 
progression of oocyte counts throughout 
the treatment of sodium butyrate in heifer 
962 
Figure 3: Line chart showing the 
progression of oocyte counts throughout 
the treatment of monensin in heifer 963 
Figure 2: Linear regression of the number of 
oocytes in 962 as the treatment of sodium 
butyrate progressed  
Figure 4: Linear regression of the number of 




































































































965 - SB/M Combination



























965 - SB/M Combination
Figure 5: Line chart showing the progression 
of oocyte counts throughout the control in 
heifer 964 
Figure 7: Line chart showing the 
progression of oocyte counts throughout 
the combination treatment in heifer 965 
Figure 6: Linear regression of the number of 
oocytes in 964 as the control treatment 
progressed  
Figure 8: Linear regression of the number of 
















































966 - SB/M Combination























































967 - Sodium Butyrate

























967 - Sodium Butyrate
Figure 9: Line chart showing the 
progression of oocyte counts throughout 
the combination treatment in heifer 966 
Figure 11: Line chart showing the 
progression of oocyte counts throughout 
the treatment of sodium butyrate in heifer 
967 
Figure 10: Linear regression of the number of 
oocytes in 966 as the combination treatment 
progressed 
Figure 12: Linear regression of the number 
of oocytes in 967 as the treatment of 






 The preliminary results suggest that both monensin and sodium butyrate are associated 
with a decrease in coccidian counts. The slopes of all the treatments were negative, indicating 
that as the heifers were being treated, the number of coccidian decreased. While the control 
group also had a negative slope, the control group had the slope of the least magnitude, with the 
exception of 962. 962 had extremely low coccidian counts, so it is very possible that in the final 
analysis this heifer will be considered an outlier. 963 experienced a spike in oocytes at 3 weeks 
of treatment with monensin and 965 experienced a peak at two weeks into treatment with the 
combination of SB/M. This could be due to the life cycle of the Eimeria species. The life cycle is 
21 days, so when an animal is infected, the oocytes will not show in the feces until about 3 
weeks later. This means that when 963 and 965 experienced peak coccidian counts at 2 and 3 
weeks, they were showing the symptoms of an infection that likely began before the treatment 
began. As previously mentioned, monensin affects only the sexually mature protozoan. 
Depending on the stage of the life cycle of the parasites, monensin may not have been effective 
immediately. 
Though preliminary, these data suggest that sodium butyrate could possibly replace 
monensin in the prevention of coccidiosis. The mechanism through which sodium butyrate could 
prevent coccidiosis in heifers is not definitively known. That being mentioned, it is possible that 
butyrate causes enough proliferation of the epithelial cells that the protozoan are not able to 
establish an infection in the epithelial cells before new epithelial cells take their place. It is also 
possible that butyrate induces the production of host defense peptides to aid the cells in the 






 While the preliminary data suggest that sodium butyrate has potential to be a replacement 
for monensin in the prevention of coccidiosis, there are details that could have affected the 
results. In this study, the concentration of sodium butyrate that was used was based off of the 
concentration in a previous study that yielded the best growth and feed efficiency, which was 
0.75g SB/kg. It was not based off of the best concentration for the prevention of coccidiosis, 
which was 0.25g SB/kg. It is likely that the results would be different if a different concentration 
of sodium butyrate was used. This needs future research to be determined.  
 The source of butyrate, sodium butyrate, could have affected the results as well. Sodium 
butyrate has a high availability and a modest price, but there are other sources of dietary 
butyrate. Sodium butyrate dissolves easily in water (Mallo et al., 2012). As a result, dietary 
sodium butyrate rapidly dissociates in the stomach and it probably mostly absorbed there, instead 
of the small intestine or colon (Guilloteau et al., 2009b). When sodium butyrate is used, it is 
unsure how much, if any, of the butyrate is being delivered to the small intestine. Calcium 
butyrate is much less soluble in water solutions compared with sodium butyrate and could 
potentially deliver more butyrate to the small intestine (Mallo et al., 2012). Another way butyrate 
could be protected to change the site of absorption is in embedded in a lipid matrix of a vegetable 
saturated fat such as palm oil; however, the exact composition of the lipid matrix is rarely 
reported (Moquet et al., 2016). When protected in the lipid matrix, butyrate is only partially 
released in the stomach and most of active substance is released in the small intestine (Piva et al., 
2007; Guilloteau et al., 2009a). This could very easily change the results because more butyrate 






There are many factors that can affect the incidence of coccidian infection in heifers, and 
ultimately skew the results. Individual differences in immunity strength could have affected the 
coccidian counts. Any type of stress can result in an infection because stress depresses immunity. 
There are many things that could have caused stress in the heifers. The process of moving from 
smaller hutches to the bigger pens could have caused stress. Stress from the enforcement of 
social hierarchy could have depressed the immunities of younger and smaller heifers. Fluctuating 
weather and over-crowding could have caused stress. Other illnesses such as ringworm and 
scours (not caused from coccidia) were observed in the heifers and they could have made heifers 
more susceptible to an infection. All of these factors could have had an effect on the results. 
There is much potential for future research regarding butyrate. The mechanism of how 
butyrate effects the tissue on a molecular level in the heifers is not understood and needs to be 
studied. It is also unclear exactly where butyrate directly affects the tissue depending on the 
source and protection of butyrate. Different sources of butyrate could potentially have different 
affects in cattle of all ages. It also unknown exactly how butyrate affects the microbiota in the 
entirety of the GIT.  The most effective dose of butyrate, source of butyrate, administration of 
butyrate, and time to be administered in the cow’s life are all still to be determined. The long-
term effects of butyrate supplementation from newborn to adulthood should also be studied. 
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